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Venous thromboembolism is a common and potentially fatal disease. Accurate diagnosis of deep vein thrombosis (DVT) and the prompt initiation of adequate treatment are essential to prevent both pulmonary emboli, recurrent thrombosis, and post-thrombosis phlebitis. The diagnosis of DVT is notoriously difficult to make as most of the symptoms and signs of the disease are non-specific. Although some patients will present to their general practitioner, many present directly to accident and emergency (A&E) departments. The numbers involved are not small. One Scandinavian study estimated an incidence of 1.6 cases of DVT per 1000 inhabitants per year,' which translates to approximately 400 patients per year in an average district general hospital. Many more patients than this will present to A&E departments with a possible DVT.
The aim of this article is to review current available diagnostic procedures and to present an algorithm aimed at improving the diagnosis of DVT in patients presenting to A&E departments.
Clinical diagnosis Diagnosing DVT on purely clinical grounds has been estimated at being correct no more than 50% of the time.' Symptoms and signs are non-specific and occur in a variety of other conditions. Previously, clinicians have been left to consider each patient's case individually and personally assign relative importance to a number of different factors such as symptoms, signs, and past or family history of DVT. This is no longer acceptable as studies have shown that the positive predictive value of informal clinical judgment is poor.23 Certain parameters were eliminated from their original model having been found to be not significantly associated with DVT when assessed by stepwise logistic regression. These included recent trauma, erythema, age, sex, duration of symptoms, and hospital admission.
A more recent study confirmed that there was no association between age and DVT.6 Additionally, male sex, orthopaedic surgery, warmth, and superficial venous dilation on examination were independent predictors of symptomatic DVT. However, this study had several limitations and until the conclusions have been prospectively evaluated in other patient populations it is probably safer to use Wells' to assess this possibility. The advantages of ultrasound over venography are that it is non-invasive, cheaper, and acceptable to patients; it is, however, very operator dependent and partial obstructions are more difficult to assess.
Colour flow duplex combines standard ultrasound with Doppler and provides a real time image with velocities of flow. It is a safe, non-invasive technique that has no specific contraindications and is repeatable, but still requires skill in interpretation.8 Colour duplex scans certainly match venography when examining the popliteal veins or more proximally, with a sensitivity of 100% and a specificity of 95% reported in one comparison study.9
Another diagnostic procedure still used in some centres is impedance plethysmography. It is an electrical signal technique that compares the electrical impedance of patent and obstructed veins. Again it is non-invasive, quick, and cheap but relies heavily on the cooperation of the patient. It has largely been superseded by ultrasound and Doppler techniques.
An article in this journal in 1998 described A number of methods are now available for detecting raised D-dimer concentrations and include the latex agglutination assay, enzyme linked immunosorbant assay (ELISA), and, more recently, whole blood agglutination assay (SimpliRED). ELISA has a high sensitivity but low specificity and is not suitable for testing in the A&E department as the kits are designed for batch assays and require several hours for processing. Latex agglutination tests can be done for individuals and have a faster turnaround time, however, sensitivity is generally too low to be used as an exclusion test in the emergency setting. SimpliRED is a novel whole blood agglutination assay that can be performed at the bedside and produces a result in just over two minutes. It utilises a bispecific antibody that has epitopes to both D-dimer and red cells. Therefore, in the presence of a raised D-dimer value, agglutination of the patient's red cells occurs that is visible to the naked eye in the test well. Several studies have assessed the reliability of this assay and reported sensitivities of 88%-100%."2 13 Various D-dimer assays are commercially available but vary in performance characteristics. This algorithm assumes a high sensitivity of the assay and this must therefore be discussed with individual laboratories.
Where imaging is not immediately available, it is not necessary to admit patients to hospital; however, it is prudent to use prophylactic subcutaneous low molecular weight heparin in these patients until the duplex scan can be performed. This should not alter the results of the scan in any way and can be given in the A&E department. It must obviously be withheld in patients with contraindications to the drug, which include uncorrected bleeding disorders, bleeding or potentially bleeding lesions, a history of heparin hypersensitivity, and a history of heparin induced thrombocytopenia or thrombosis.
Current practice in most centres is still to admit patients with a positive diagnosis of DVT for the start of anticoagulation treatment. With the advent of the use of low molecular weight heparin it may become increasingly possible to treat as well as diagnose this disease as an outpatient. The team at Chertsey described a regimen for managing anticoagulation as an outpatient that was safe, acceptable to patients and staff, and avoided admission to hospital in most patients with uncomplicated DVT.'0 Conflict of interest: none. Read Lensing et al (Lancet 1999; 353:479-85 ) and name the inherited prothrombotic abnormalities that may be found in some patients with a first episode of vein thrombosis.
